Inventor · disambiguated record
Anahit Ghochikyan
Also filed as: GHOCHIKYAN ANAHIT
5 granted patents·4 pending applications·17 citations·filing 2004–2017
73Inventor score
Files withGHOCHIKYAN ANAHIT2AGADJANYAN MICHAEL G1INST FOR MOLECULAR MEDCINE INC1INST MOLECULAR MEDICINE1ONCOMUNE LLC1
Top patents by PatentIndex Score
9 records- 0173US7186525B2Methods of RNA and protein synthesisUNIV NANTES·Filed 2004·Granted Mar 6, 2007·10 cites·28 claims
- 0271US10570196B2Humanized anti-tau antibodies and compositions for and methods of making and using in treatment, diagnosis and monitoring of tauopathiesGHOCHIKYAN ANAHIT·Filed 2017·Granted Feb 25, 2020·3 cites·13 claims
- 0370US10005825B2Compositions and methods related to diseases associated with deposits of amyloid, tau, and alpha-synucleinINST FOR MOLECULAR MEDCINE INC·Filed 2015·Granted Jun 26, 2018·3 cites·21 claims
- 0465US8114405B2Cancer vaccine based on brother of regulator of imprinted sites molecule (BORIS)AGADJANYAN MICHAEL G·Filed 2009·Granted Feb 14, 2012·0 cites·24 claims
- 0560US7579452B2Cancer vaccine based on brother of regulator of imprinted sites moleculeONCOMUNE LLC·Filed 2004·Granted Aug 25, 2009·1 cites·24 claims
- 0641US2017143812A1Exosome mediated innate and adaptive immune stimulation for treatment of cancerTHERAPEUTIC SOLUTIONS INT INC·Filed 2016·Application pending·0 cites
- 0740US2014056901A1Anti-tau antibodies and compositions for and methods of making and using in treatment, diagnosis and monitoring of tauopathiesINST MOLECULAR MEDICINE·Filed 2013·Application pending·0 cites
- 0838US2017368167A9Compositions and methods related to neurological disordersTHE INST FOR MOLECULAR MEDICINE·Filed 2016·Application pending·0 cites
- 0932US2017274069A1Method for the cancer treatment and prevention of metastatic diseaseGHOCHIKYAN ANAHIT·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Anahit Ghochikyan files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →